[1]
Li, D.-L., Wei, Z.-L., Zhang, W.-M. and Li, Z.-G. 2015. Anti-tumor activity of cabozantinib by FAK down-regulation in human oral squamous cell carcinoma. Bangladesh Journal of Pharmacology. 11, 1 (Dec. 2015), 119–125. DOI:https://doi.org/10.3329/bjp.v11i1.24001.